2019 Q1 Form 10-Q Financial Statement
#000156459020020242 Filed on April 30, 2020
Income Statement
| Concept | 2019 Q1 |
|---|---|
| Revenue | $43.20M |
| YoY Change | 26.61% |
| Cost Of Revenue | |
| YoY Change | |
| Gross Profit | |
| YoY Change | |
| Gross Profit Margin | |
| Selling, General & Admin | |
| YoY Change | |
| % of Gross Profit | |
| Research & Development | |
| YoY Change | |
| % of Gross Profit | |
| Depreciation & Amortization | $1.700M |
| YoY Change | 54.55% |
| % of Gross Profit | |
| Operating Expenses | |
| YoY Change | |
| Operating Profit | |
| YoY Change | |
| Interest Expense | $12.56M |
| YoY Change | 98.28% |
| % of Operating Profit | |
| Other Income/Expense, Net | |
| YoY Change | |
| Pretax Income | -$5.226M |
| YoY Change | -146.49% |
| Income Tax | -$1.153M |
| % Of Pretax Income | |
| Net Earnings | -$4.073M |
| YoY Change | -146.76% |
| Net Earnings / Revenue | -9.43% |
| Basic Earnings Per Share | -$0.26 |
| Diluted Earnings Per Share | -$0.26 |
| COMMON SHARES | |
| Basic Shares Outstanding | 15.80M |
| Diluted Shares Outstanding | 15.80M |
Balance Sheet
| Concept | 2019 Q1 |
|---|---|
| SHORT-TERM ASSETS | |
| Cash & Short-Term Investments | |
| YoY Change | |
| Cash & Equivalents | $167.5M |
| Short-Term Investments | |
| Other Short-Term Assets | |
| YoY Change | |
| Inventory | |
| Prepaid Expenses | |
| Receivables | |
| Other Receivables | |
| Total Short-Term Assets | |
| YoY Change | |
| LONG-TERM ASSETS | |
| Property, Plant & Equipment | $84.90M |
| YoY Change | 35.62% |
| Goodwill | |
| YoY Change | |
| Intangibles | |
| YoY Change | |
| Long-Term Investments | |
| YoY Change | |
| Other Assets | |
| YoY Change | |
| Total Long-Term Assets | |
| YoY Change | |
| TOTAL ASSETS | |
| Total Short-Term Assets | |
| Total Long-Term Assets | |
| Total Assets | $4.065B |
| YoY Change | 28.0% |
| SHORT-TERM LIABILITIES | |
| YoY Change | |
| Accounts Payable | $12.50M |
| YoY Change | 26.26% |
| Accrued Expenses | $3.300M |
| YoY Change | |
| Deferred Revenue | |
| YoY Change | |
| Short-Term Debt | $43.40M |
| YoY Change | 3.09% |
| Long-Term Debt Due | |
| YoY Change | |
| Total Short-Term Liabilities | $15.80M |
| YoY Change | 59.6% |
| LONG-TERM LIABILITIES | |
| Long-Term Debt | $22.80M |
| YoY Change | 38.18% |
| Other Long-Term Liabilities | $4.000M |
| YoY Change | 100.0% |
| Total Long-Term Liabilities | $26.80M |
| YoY Change | 44.86% |
| TOTAL LIABILITIES | |
| Total Short-Term Liabilities | $15.80M |
| Total Long-Term Liabilities | $26.80M |
| Total Liabilities | $3.612B |
| YoY Change | 29.25% |
| SHAREHOLDERS EQUITY | |
| Retained Earnings | |
| YoY Change | |
| Common Stock | |
| YoY Change | |
| Preferred Stock | |
| YoY Change | |
| Treasury Stock (at cost) | |
| YoY Change | |
| Treasury Stock Shares | |
| Shareholders Equity | $453.5M |
| YoY Change | |
| Total Liabilities & Shareholders Equity | $4.065B |
| YoY Change | 28.0% |
Cashflow Statement
| Concept | 2019 Q1 |
|---|---|
| OPERATING ACTIVITIES | |
| Net Income | -$4.073M |
| YoY Change | -146.76% |
| Depreciation, Depletion And Amortization | $1.700M |
| YoY Change | 54.55% |
| Cash From Operating Activities | $12.75M |
| YoY Change | 25.17% |
| INVESTING ACTIVITIES | |
| Capital Expenditures | $1.261M |
| YoY Change | 54.91% |
| Acquisitions | |
| YoY Change | |
| Other Investing Activities | $57.70M |
| YoY Change | -431.61% |
| Cash From Investing Activities | $56.44M |
| YoY Change | -410.56% |
| FINANCING ACTIVITIES | |
| Cash Dividend Paid | |
| YoY Change | |
| Common Stock Issuance & Retirement, Net | |
| YoY Change | |
| Debt Paid & Issued, Net | |
| YoY Change | |
| Cash From Financing Activities | -94.55M |
| YoY Change | 8803.3% |
| NET CHANGE | |
| Cash From Operating Activities | 12.75M |
| Cash From Investing Activities | 56.44M |
| Cash From Financing Activities | -94.55M |
| Net Change In Cash | -25.37M |
| YoY Change | 180.31% |
| FREE CASH FLOW | |
| Cash From Operating Activities | $12.75M |
| Capital Expenditures | $1.261M |
| Free Cash Flow | $11.49M |
| YoY Change | 22.59% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2020Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
9000 | |
| CY2020Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
8000 | |
| CY2019Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
6000 | |
| CY2020Q1 | us-gaap |
Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
|
157000 | |
| CY2019Q1 | us-gaap |
Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
|
852000 | |
| CY2020Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
5306000 | |
| CY2019Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
5324000 | |
| CY2020Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
13504000 | |
| CY2019Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
14098000 | |
| CY2020Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
2235000 | |
| CY2019Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
1967000 | |
| CY2020Q1 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
2663000 | |
| CY2019Q1 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
2405000 | |
| CY2020Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
1367000 | |
| CY2019Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
1156000 | |
| CY2020Q1 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
696000 | |
| CY2019Q1 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
646000 | |
| CY2020Q1 | us-gaap |
Communication
Communication
|
487000 | |
| CY2019Q1 | us-gaap |
Communication
Communication
|
585000 | |
| CY2020Q1 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
517000 | |
| CY2019Q1 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
278000 | |
| CY2020Q1 | us-gaap |
Postage Expense
PostageExpense
|
384000 | |
| CY2019Q1 | us-gaap |
Postage Expense
PostageExpense
|
327000 | |
| CY2020Q1 | eqbk |
Free Nationwide Atm Cost
FreeNationwideATMCost
|
420000 | |
| CY2019Q1 | eqbk |
Free Nationwide Atm Cost
FreeNationwideATMCost
|
361000 | |
| CY2020Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
802000 | |
| CY2019Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
779000 | |
| CY2020Q1 | us-gaap |
Loan Processing Fee
LoanProcessingFee
|
234000 | |
| CY2019Q1 | us-gaap |
Loan Processing Fee
LoanProcessingFee
|
268000 | |
| CY2020Q1 | us-gaap |
Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
|
-308000 | |
| CY2019Q1 | us-gaap |
Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
|
-112000 | |
| CY2019Q1 | us-gaap |
Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
|
639000 | |
| CY2020Q1 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
2141000 | |
| CY2019Q1 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
1922000 | |
| CY2020Q1 | us-gaap |
Noninterest Expense
NoninterestExpense
|
25758000 | |
| CY2019Q1 | us-gaap |
Noninterest Expense
NoninterestExpense
|
25543000 | |
| CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1703000 | |
| CY2019Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5226000 | |
| CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
445000 | |
| CY2019Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1153000 | |
| CY2020Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
1258000 | |
| CY2019Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4073000 | |
| CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.08 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.26 | |
| CY2020Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.08 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.26 | |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1258000 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4073000 | |
| CY2020Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
4862000 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
2520000 | |
| CY2020Q1 | eqbk |
Other Comprehensive Income Loss Amortization Of Net Unrealized Gain Loss On Transfers To Held To Maturity From Available For Sale Securities Before Tax
OtherComprehensiveIncomeLossAmortizationOfNetUnrealizedGainLossOnTransfersToHeldToMaturityFromAvailableForSaleSecuritiesBeforeTax
|
177000 | |
| CY2019Q1 | eqbk |
Other Comprehensive Income Loss Amortization Of Net Unrealized Gain Loss On Transfers To Held To Maturity From Available For Sale Securities Before Tax
OtherComprehensiveIncomeLossAmortizationOfNetUnrealizedGainLossOnTransfersToHeldToMaturityFromAvailableForSaleSecuritiesBeforeTax
|
293000 | |
| CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
5039000 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
2813000 | |
| CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
1267000 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
713000 | |
| CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
3772000 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
2100000 | |
| CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
5030000 | |
| CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-1973000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
455941000 | |
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
734000 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
112000 | |
| CY2019Q1 | eqbk |
Employee Stock Loans Repayments Value
EmployeeStockLoansRepaymentsValue
|
34000 | |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
453463000 | |
| CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
756000 | |
| CY2020Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
354000 | |
| CY2020Q1 | eqbk |
Employee Stock Loans Repayments Value
EmployeeStockLoansRepaymentsValue
|
34000 | |
| CY2020Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
6892000 | |
| CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
756000 | |
| CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
734000 | |
| CY2020Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
933000 | |
| CY2019Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
863000 | |
| CY2020Q1 | eqbk |
Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
|
153000 | |
| CY2019Q1 | eqbk |
Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
|
148000 | |
| CY2020Q1 | eqbk |
Amortization Of Cloud Computing Implementation Costs
AmortizationOfCloudComputingImplementationCosts
|
27000 | |
| CY2019Q1 | eqbk |
Amortization Of Cloud Computing Implementation Costs
AmortizationOfCloudComputingImplementationCosts
|
20000 | |
| CY2020Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
906000 | |
| CY2019Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
1233000 | |
| CY2020Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
1471000 | |
| CY2019Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
1288000 | |
| CY2020Q1 | eqbk |
Amortization Of Intangibles
AmortizationOfIntangibles
|
814000 | |
| CY2019Q1 | eqbk |
Amortization Of Intangibles
AmortizationOfIntangibles
|
791000 | |
| CY2020Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
257000 | |
| CY2019Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-14000 | |
| CY2020Q1 | eqbk |
Increase Decrease In Federal Home Loan Bank Stock Dividends
IncreaseDecreaseInFederalHomeLoanBankStockDividends
|
-265000 | |
| CY2019Q1 | eqbk |
Increase Decrease In Federal Home Loan Bank Stock Dividends
IncreaseDecreaseInFederalHomeLoanBankStockDividends
|
-184000 | |
| CY2020Q1 | eqbk |
Gain Loss On Sales And Valuation Adjustments On Other Real Estate Owned
GainLossOnSalesAndValuationAdjustmentsOnOtherRealEstateOwned
|
-177000 | |
| CY2019Q1 | eqbk |
Gain Loss On Sales And Valuation Adjustments On Other Real Estate Owned
GainLossOnSalesAndValuationAdjustmentsOnOtherRealEstateOwned
|
21000 | |
| CY2019Q1 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
6000 | |
| CY2020Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
8000 | |
| CY2019Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
10000 | |
| CY2020Q1 | eqbk |
Gain Loss On Foreclosed Assets
GainLossOnForeclosedAssets
|
-27000 | |
| CY2019Q1 | eqbk |
Gain Loss On Foreclosed Assets
GainLossOnForeclosedAssets
|
-15000 | |
| CY2020Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
478000 | |
| CY2019Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
260000 | |
| CY2020Q1 | eqbk |
Originations Of Loans Held For Sale
OriginationsOfLoansHeldForSale
|
23381000 | |
| CY2019Q1 | eqbk |
Originations Of Loans Held For Sale
OriginationsOfLoansHeldForSale
|
11448000 | |
| CY2020Q1 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
23298000 | |
| CY2019Q1 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
12540000 | |
| CY2020Q1 | us-gaap |
Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
|
482000 | |
| CY2019Q1 | us-gaap |
Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
|
488000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
|
-495000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
|
1342000 | |
| CY2020Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
178000 | |
| CY2019Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
222000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-189000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-965000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
4448000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
156000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
|
-1100000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
|
-803000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
8549000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
12750000 | |
| CY2020Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
50368000 | |
| CY2020Q1 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
2754000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
27022000 | |
| CY2020Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
9023000 | |
| CY2019Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
4602000 | |
| CY2020Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
48989000 | |
| CY2019Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
23942000 | |
| CY2019Q1 | us-gaap |
Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
|
249000 | |
| CY2020Q1 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
-50501000 | |
| CY2019Q1 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
36465000 | |
| CY2020Q1 | eqbk |
Payments To Acquire Other Real Estate1
PaymentsToAcquireOtherRealEstate1
|
52000 | |
| CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1204000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1261000 | |
| CY2020Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
17000 | |
| CY2019Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
10000 | |
| CY2020Q1 | us-gaap |
Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
|
97000 | |
| CY2019Q1 | us-gaap |
Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
|
73000 | |
| CY2020Q1 | eqbk |
Payments For Proceeds From Federal Home Loan Bank Stock And Federal Reserve Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStockAndFederalReserveBankStock
|
260000 | |
| CY2019Q1 | eqbk |
Payments For Proceeds From Federal Home Loan Bank Stock And Federal Reserve Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStockAndFederalReserveBankStock
|
-6829000 | |
| CY2020Q1 | us-gaap |
Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
|
2455000 | |
| CY2019Q1 | us-gaap |
Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
|
121000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
56444000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
56438000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
-103149000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
38824000 | |
| CY2020Q1 | us-gaap |
Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
|
1405000 | |
| CY2019Q1 | us-gaap |
Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
|
-6635000 | |
| CY2020Q1 | eqbk |
Proceeds From Repayments Of Federal Home Loan Bank Borrowings
ProceedsFromRepaymentsOfFederalHomeLoanBankBorrowings
|
-184223000 | |
| CY2019Q1 | eqbk |
Proceeds From Repayments Of Federal Home Loan Bank Borrowings
ProceedsFromRepaymentsOfFederalHomeLoanBankBorrowings
|
-119429000 | |
| CY2020Q1 | us-gaap |
Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
|
250000000 | |
| CY2020Q1 | us-gaap |
Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
|
525000 | |
| CY2019Q1 | us-gaap |
Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
|
509000 | |
| CY2020Q1 | us-gaap |
Proceeds From Bank Debt
ProceedsFromBankDebt
|
38354000 | |
| CY2020Q1 | us-gaap |
Repayments Of Bank Debt
RepaymentsOfBankDebt
|
7344000 | |
| CY2019Q1 | us-gaap |
Repayments Of Bank Debt
RepaymentsOfBankDebt
|
6950000 | |
| CY2020Q1 | eqbk |
Principal Receivables On Employee Stock Loan
PrincipalReceivablesOnEmployeeStockLoan
|
34000 | |
| CY2019Q1 | eqbk |
Principal Receivables On Employee Stock Loan
PrincipalReceivablesOnEmployeeStockLoan
|
34000 | |
| CY2020Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
9000 | |
| CY2019Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
112000 | |
| CY2020Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
354000 | |
| CY2020Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
6892000 | |
| CY2020Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-55000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-12032000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-94553000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
52961000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-25365000 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
89291000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
192818000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
142252000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
167453000 | |
| CY2020Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
8942000 | |
| CY2019Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
11418000 | |
| CY2020Q1 | us-gaap |
Transfer To Other Real Estate
TransferToOtherRealEstate
|
157000 | |
| CY2019Q1 | us-gaap |
Transfer To Other Real Estate
TransferToOtherRealEstate
|
111000 | |
| CY2019Q1 | eqbk |
Noncash Or Part Noncash Operating Leases Recognized
NoncashOrPartNoncashOperatingLeasesRecognized
|
3546000 | |
| CY2020Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Reclassifications</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some items in prior financial statements were reclassified to conform to the current presentation. Management determined the items reclassified are immaterial to the consolidated financial statements taken as a whole and did not result in a change in equity or net income for the periods reported.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Risk and Uncertainties</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The outbreak of COVID-19 has adversely impacted a broad range of industries in which the Company’s customers operate and could impair their ability to fulfill their financial obligations to the Company. The World Health Organization has declared COVID-19 to be a global pandemic indicating that almost all public commerce and related business activities must be, to varying degrees, curtailed with the goal of decreasing the rate of new infections. The spread of the outbreak has caused significant disruptions in the U.S. economy and has disrupted banking and other financial activity in the areas in which the Company operates. While there has been no material impact to the Company’s employees to date, COVID-19 could also potentially create widespread business continuity issues for the Company.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Congress, the President, and the Federal Reserve have taken several actions designed to cushion the economic fallout. Most notably, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act was signed into law at the end of March 2020 as a $2 trillion legislative package. The goal of the CARES Act is to prevent a severe economic downturn through various measures, including direct financial aid to American families and economic stimulus to significantly impacted industry sectors. The package also includes extensive emergency funding for hospitals and medical providers. In addition to the general impact of COVID-19, certain provisions of the CARES Act as well as other recent legislative and regulatory relief efforts are expected to have a material impact on the Company’s operations.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s business is dependent upon the willingness and ability of its employees and customers to conduct banking and other financial transactions. If the global response to contain COVID-19 is unsuccessful, the Company could experience a material adverse effect on its business, financial condition, results of operations and cash flows. While it is not possible to know the full universe or extent that the impact of COVID-19, and resulting measures to curtail its spread, will have on the Company’s operations, the Company is disclosing potentially material items of which it is aware of.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.58%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Financial position and results of operations</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s interest income and fees could be reduced due to COVID-19. In keeping with guidance from regulators, the Company is actively working with COVID-19 affected borrowers to defer their payments, interest, and fees. While interest and fees will still accrue to income, through normal GAAP accounting, should eventual credit losses on these deferred payments emerge, interest income and fees accrued would need to be reversed. In such a scenario, interest income in future periods could be negatively impacted. At this time, the Company is unable to project the materiality of such an impact, but recognizes the breadth of the economic impact may affect its borrowers’ ability to repay in future periods.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Capital and liquidity</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2020, all our capital ratios, and our subsidiary bank’s capital ratios, were in excess of regulatory requirements. While we are currently classified as well capitalized, an extended economic recession brought about by COVID-19, could adversely impact our reported and regulatory capital ratios by further credit losses. The Company relies on cash on hand as well as dividends from its subsidiary bank to service its debt. If the Company’s subsidiary bank’s capital deteriorates such that it is unable to pay dividends to the Company for an extended period of time, the Company may not be able to service its debt.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains access to multiple sources of liquidity. Wholesale funding markets have remained open to us, but rates for short term funding have recently been volatile. If funding costs are elevated for an extended period of time, it could have an adverse effect on the Company’s net interest margin. If an extended recession caused large numbers of the Company’s deposit customers to withdraw their funds, the Company might become more reliant on volatile or more expensive sources of funding.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.58%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Asset valuation</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Currently, the Company does not expect COVID-19 to affect its ability to account timely for the assets on its balance sheet; however, this could change in future periods. While certain valuation assumptions and judgments will change to account for pandemic-related circumstances such as widening credit spreads, the Company does not anticipate significant changes in methodology used to determine the fair value of assets measured in accordance with GAAP.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19 could cause a further and sustained decline in the Company’s stock price, which may require further quantitative and qualitative analysis and could result in an impairment charge being recorded for that period. In the event that the Company concludes that all or a portion of its goodwill is impaired, a non-cash charge for the amount of such impairment would be recorded to earnings. Such a charge would have no impact on tangible capital or regulatory capital.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.58%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Processes, controls and business continuity plan</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has invoked a preparedness plan that includes breaking up onsite work departments and remote working strategy for part of the Company’s staff. The Company does not anticipate incurring additional material cost related to its continued deployment of the preparedness plan and no material operational or internal control challenges or risks have been identified to date. The Company does not anticipate significant challenges to its ability to maintain its systems and controls in light of the measures the Company has taken to prevent the spread of COVID-19. The Company does not currently face any material resource constraint through the implementation of its business continuity plans.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Lending operations and accommodations to borrowers</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In keeping with regulatory guidance to work with borrowers during this unprecedented situation and as outlined in the CARES Act, the Company is executing a payment deferral program for its lending clients that are adversely affected by the pandemic. Depending on the demonstrated need of the client, the Company is deferring either the full loan payment or the principal component of the loan payment for 90 or 180 days. As of April 27, 2020, the Company has executed 927 of these deferrals on outstanding loan balances of $474,658. In accordance with interagency guidance issued in March 2020, these short term deferrals are not considered troubled debt restructurings.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With the passage of the Paycheck Protection Program (“PPP”), administered by the Small Business Administration (“SBA”), the Company is actively participating in assisting its customers with applications for resources through the program. PPP loans have a two-year term and earn interest at 1%. As of April 27, 2020, the Company has closed or approved with the SBA 1,776 PPP loans representing $470,127 in funding. It is the Company’s understanding that loans funded through the PPP program are fully guaranteed by the U.S. government. Should those circumstances change, the Company could be required to establish additional allowance for loan loss through additional provision for loan loss expense charged to earnings.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Credit</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is working with customers directly affected by COVID-19. The Company is prepared to offer short-term assistance in accordance with regulatory guidelines. As a result of the current economic environment caused by the COVID-19 virus, the Company is engaging in frequent communication with borrowers to better understand their situation and the challenges faced, allowing it to respond proactively as needs and issues arise. Should economic conditions worsen, the Company could experience further increases in its required allowance for loan losses and record additional provision for loan losses. It is possible that the Company’s asset quality measures could worsen at future measurement periods if the effects of COVID-19 are prolonged.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All industries have and will continue to experience adverse impacts as a result of the COVID-19 virus. Our exposure from outstanding loans and commitments totaled approximately $239,900 in hospitality, approximately $222,200 in construction, approximately $144,200 in retail, approximately $96,400 in restaurants, approximately $85,100 in multifamily properties, approximately $62,900 in aircraft manufacturing and approximately $45,200 in syndicated national credits.</p> | |
| CY2020Q2 | eqbk |
Cares Act Financing Receivable Modifications Number Of Contracts
CARESActFinancingReceivableModificationsNumberOfContracts
|
927 | |
| CY2020Q2 | eqbk |
Cares Act Financing Receivable Loan Modifications
CARESActFinancingReceivableLoanModifications
|
474658 | |
| CY2020Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
181965000 | |
| CY2019Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
141082000 | |
| CY2020Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
5858000 | |
| CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
1261000 | |
| CY2020Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
11000 | |
| CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
276000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
|
29925000 | |
| CY2020Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
2264000 | |
| CY2019Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
32466000 | |
| CY2020Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
11000 | |
| CY2019Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
273000 | |
| CY2020Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
2264000 | |
| CY2019Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
34483000 | |
| CY2020Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
11000 | |
| CY2019Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
276000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
13191000 | |
| CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
28828000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
994000 | |
| CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
69000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
5558000 | |
| CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
99340000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
26000 | |
| CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
661000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
|
18749000 | |
| CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
|
128168000 | |
| CY2019Q4 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
|
15414000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
1017000 | |
| CY2019Q4 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
562000 | |
| CY2020Q1 | us-gaap |
Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
|
181965000 | |
| CY2020Q1 | us-gaap |
Mortgage Backed Securities Available For Sale Fair Value Disclosure
MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
|
187812000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
5495000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
|
33555000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
|
53778000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Debt Maturities After Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount
|
67906000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Without Single Maturity Date Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount
|
561258000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
5525000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
34380000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Debt Maturities After Five Through Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
54682000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Debt Maturities After Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue
|
69454000 | |
| CY2020Q1 | us-gaap |
Mortgage Backed Securities Held To Maturity Fair Value Disclosure
MortgageBackedSecuritiesHeldToMaturityFairValueDisclosure
|
586859000 | |
| CY2020Q1 | us-gaap |
Securities Held As Collateral At Fair Value
SecuritiesHeldAsCollateralAtFairValue
|
748333000 | |
| CY2019Q4 | us-gaap |
Securities Held As Collateral At Fair Value
SecuritiesHeldAsCollateralAtFairValue
|
780038000 | |
| CY2019Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
2017000 | |
| CY2019Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
3000 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
1020000 | |
| CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
730000 | |
| CY2020Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
|
1 | |
| CY2020Q1 | us-gaap |
Held To Maturity Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions
HeldToMaturitySecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions
|
46 | |
| CY2020Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
0 | |
| CY2019Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
0 | |
| CY2020Q1 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
2507123000 | |
| CY2019Q4 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
2556652000 | |
| CY2020Q1 | eqbk |
Unamortized Merger Purchase Accounting Adjustments Balance
UnamortizedMergerPurchaseAccountingAdjustmentsBalance
|
7380000 | |
| CY2019Q4 | eqbk |
Unamortized Merger Purchase Accounting Adjustments Balance
UnamortizedMergerPurchaseAccountingAdjustmentsBalance
|
8287000 | |
| CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
357000 | |
| CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
100000 | |
| CY2018Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
11454000 | |
| CY2019Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
938000 | |
| CY2019Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
178000 | |
| CY2019Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
26340000 | |
| CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
|
2122000 | |
| CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
18845000 | |
| CY2020Q1 | eqbk |
Allowance For Loan Losses Purchased Credit Impaired Loans
AllowanceForLoanLossesPurchasedCreditImpairedLoans
|
948000 | |
| CY2020Q1 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
29664000 | |
| CY2020Q1 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
2455510000 | |
| CY2020Q1 | eqbk |
Financing Receivable Purchase Credit Impaired Loans
FinancingReceivablePurchaseCreditImpairedLoans
|
21949000 | |
| CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
|
935000 | |
| CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
11017000 | |
| CY2019Q4 | eqbk |
Allowance For Loan Losses Purchased Credit Impaired Loans
AllowanceForLoanLossesPurchasedCreditImpairedLoans
|
280000 | |
| CY2019Q4 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
29551000 | |
| CY2019Q4 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
2503711000 | |
| CY2019Q4 | eqbk |
Financing Receivable Purchase Credit Impaired Loans
FinancingReceivablePurchaseCreditImpairedLoans
|
23390000 | |
| CY2020Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
|
25921000 | |
| CY2020Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
|
19484000 | |
| CY2019Q4 | us-gaap |
Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
|
28323000 | |
| CY2019 | us-gaap |
Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
|
22839000 | |
| CY2020Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
|
21162000 | |
| CY2020Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
|
28000 | |
| CY2019Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
|
17711000 | |
| CY2019Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
|
1000 | |
| CY2020Q1 | us-gaap |
Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
|
15548000 | |
| CY2020Q1 | us-gaap |
Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod
|
1000 | |
| CY2019Q1 | us-gaap |
Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
|
34810000 | |
| CY2019Q1 | us-gaap |
Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod
|
76000 | |
| CY2020Q1 | us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
36710000 | |
| CY2020Q1 | us-gaap |
Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
|
29000 | |
| CY2019Q1 | us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
52521000 | |
| CY2019Q1 | us-gaap |
Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
|
77000 | |
| CY2020Q1 | us-gaap |
Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
|
83000 | |
| CY2020Q1 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
42059000 | |
| CY2020Q1 | us-gaap |
Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
|
2445240000 | |
| CY2020Q1 | us-gaap |
Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
|
15084000 | |
| CY2019Q4 | us-gaap |
Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
|
15508000 | |
| CY2020Q1 | eqbk |
Financing Receivable Tdr Allowance
FinancingReceivableTDRAllowance
|
94000 | |
| CY2019Q4 | eqbk |
Financing Receivable Tdr Allowance
FinancingReceivableTDRAllowance
|
0 | |
| CY2020Q1 | us-gaap |
Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
|
0 | |
| CY2019Q4 | us-gaap |
Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
|
0 | |
| CY2020Q1 | us-gaap |
Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
|
0 | |
| CY2019Q1 | us-gaap |
Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
|
0 | |
| CY2019 | us-gaap |
Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
|
0 | |
| CY2020 | us-gaap |
Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
|
0 | |
| CY2020Q2 | eqbk |
Cares Act Of2020 Aid Amount
CARESActOf2020AidAmount
|
470127000 | |
| CY2020Q1 | us-gaap |
Derivative Notional Amount
DerivativeNotionalAmount
|
120031000 | |
| CY2020Q1 | us-gaap |
Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
|
7673000 | |
| CY2020Q1 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
9108000 | |
| CY2019Q4 | us-gaap |
Derivative Notional Amount
DerivativeNotionalAmount
|
120368000 | |
| CY2019Q4 | us-gaap |
Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
|
3535000 | |
| CY2019Q4 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
4076000 | |
| CY2020Q1 | us-gaap |
Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
|
8955000 | |
| CY2019Q4 | us-gaap |
Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
|
4186000 | |
| CY2020Q1 | eqbk |
Derivative Asset Netting Adjustment
DerivativeAssetNettingAdjustment
|
72000 | |
| CY2020Q1 | eqbk |
Derivative Liability Netting Adjustment
DerivativeLiabilityNettingAdjustment
|
72000 | |
| CY2019Q4 | eqbk |
Derivative Asset Netting Adjustment
DerivativeAssetNettingAdjustment
|
182000 | |
| CY2019Q4 | eqbk |
Derivative Liability Netting Adjustment
DerivativeLiabilityNettingAdjustment
|
182000 | |
| CY2020Q1 | us-gaap |
Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
|
7745000 | |
| CY2020Q1 | us-gaap |
Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
|
225000 | |
| CY2019Q4 | us-gaap |
Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
|
3717000 | |
| CY2019Q4 | us-gaap |
Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
|
72000 | |
| CY2020Q1 | us-gaap |
Hedged Asset Fair Value Hedge
HedgedAssetFairValueHedge
|
5743000 | |
| CY2020Q1 | us-gaap |
Hedged Asset Fair Value Hedge Cumulative Increase Decrease
HedgedAssetFairValueHedgeCumulativeIncreaseDecrease
|
545000 | |
| CY2020Q1 | us-gaap |
Gain Loss On Fair Value Hedge Ineffectiveness Net
GainLossOnFairValueHedgeIneffectivenessNet
|
0 | |
| CY2019Q1 | us-gaap |
Gain Loss On Fair Value Hedge Ineffectiveness Net
GainLossOnFairValueHedgeIneffectivenessNet
|
0 | |
| CY2020Q1 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
-492000 | |
| CY2019Q1 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
-61000 | |
| CY2020Q1 | eqbk |
Gain Loss On Derivative Instruments And Hedging Activities Net Pretax
GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax
|
-492000 | |
| CY2019Q1 | eqbk |
Gain Loss On Derivative Instruments And Hedging Activities Net Pretax
GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax
|
-61000 | |
| CY2020Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4000000 | |
| CY2020Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
3964000 | |
| CY2020Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P16Y2M12D | |
| CY2020Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0296 | |
| CY2019Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4153000 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
4112000 | |
| CY2019Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P16Y | |
| CY2019Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0295 | |
| CY2020Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
182000 | |
| CY2019Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
173000 | |
| CY2020Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
11000 | |
| CY2019Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
13000 | |
| CY2020Q1 | us-gaap |
Lease Cost
LeaseCost
|
193000 | |
| CY2019Q1 | us-gaap |
Lease Cost
LeaseCost
|
186000 | |
| CY2020Q1 | us-gaap |
Lessor Sales Type Lease Lease Not Yet Commenced Description
LessorSalesTypeLeaseLeaseNotYetCommencedDescription
|
There were no sales and leaseback transactions, leverage leases, lease transactions with related parties or leases that had not yet commenced during the three-month period ended March 31, 2020. | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
606000 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
503000 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
493000 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
328000 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
214000 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
2994000 | |
| CY2020Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
5138000 | |
| CY2020Q1 | eqbk |
Lessee Operating Lease Liability Discounted Amount
LesseeOperatingLeaseLiabilityDiscountedAmount
|
1174000 | |
| CY2020Q1 | us-gaap |
Federal Funds Purchased
FederalFundsPurchased
|
0 | |
| CY2019Q4 | us-gaap |
Federal Funds Purchased
FederalFundsPurchased
|
0 | |
| CY2020Q1 | us-gaap |
Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
|
37113000 | |
| CY2019Q4 | us-gaap |
Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
|
35708000 | |
| CY2020Q1 | eqbk |
Securities Sold Under Agreements To Repurchase Average Balance Of Agreements Outstanding
SecuritiesSoldUnderAgreementsToRepurchaseAverageBalanceOfAgreementsOutstanding
|
35800000 | |
| CY2017Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
30000000 | |
| CY2019 | eqbk |
Securities Sold Under Agreements To Repurchase Average Balance Of Agreements Outstanding
SecuritiesSoldUnderAgreementsToRepurchaseAverageBalanceOfAgreementsOutstanding
|
42459000 | |
| CY2020Q1 | us-gaap |
Line Of Credit Facility Maximum Monthend Outstanding Amount
LineOfCreditFacilityMaximumMonthendOutstandingAmount
|
37113000 | |
| CY2019 | us-gaap |
Line Of Credit Facility Maximum Monthend Outstanding Amount
LineOfCreditFacilityMaximumMonthendOutstandingAmount
|
45575000 | |
| CY2020Q1 | us-gaap |
Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
|
0.0036 | |
| CY2019Q4 | us-gaap |
Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
|
0.0040 | |
| CY2019Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
40000000 | |
| CY2020Q1 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2020-05-15 | |
| CY2017Q1 | us-gaap |
Debt Instrument Term
DebtInstrumentTerm
|
P5Y | |
| CY2017Q1 | us-gaap |
Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
|
0.0020 | |
| CY2020Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
| CY2020Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2019Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2020Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
295461 | |
| CY2020Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
23.33 | |
| CY2020Q1 | eqbk |
Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
|
0.065 | |
| CY2020Q1 | us-gaap |
Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
|
0.08 | |
| CY2020Q1 | us-gaap |
Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
|
0.10 | |
| CY2020Q1 | us-gaap |
Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
|
0.05 | |
| CY2020Q1 | eqbk |
Capital Conservation Buffer Required For Capital Adequacy
CapitalConservationBufferRequiredForCapitalAdequacy
|
0.025 | |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
15384667 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
15799974 | |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
3030 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
4534 | |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
15387697 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
15804508 | |
| CY2020Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
1258000 | |
| CY2019Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-4073000 | |
| CY2020Q1 | us-gaap |
Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
|
32579 | |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15595024 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15804508 | |
| CY2020Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
454660 | |
| CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
585099 | |
| CY2020Q1 | eqbk |
Fair Value Assets And Liabilities Levels Transfers Amount
FairValueAssetsAndLiabilitiesLevelsTransfersAmount
|
0 | |
| CY2019 | eqbk |
Fair Value Assets And Liabilities Levels Transfers Amount
FairValueAssetsAndLiabilitiesLevelsTransfersAmount
|
0 | |
| CY2019Q4 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
1474000 | |
| CY2019Q2 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
14500000 |
